Zephyrus Biosciences
Berkeley, US · Founded 2013 · 1 known investors
Biotech
Founders & leadership
KG
Kelly GardnerNamed on SEC filing
EH
Elaine HeronNamed on SEC filing
JM
Joshua MolhoNamed on SEC filing
DC
Douglas CrawfordNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$300K disclosed across 1 round · 2014
▶$300KraisedSep 2014 · 5 investors · BiotechnologyRule 506(b)
▶$300KraisedSep 2014 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kelly GardnerExecutive Officer, Director
- Elaine HeronDirector
- Joshua MolhoExecutive Officer, Director
- Douglas CrawfordDirector
- Offering amount
- $300.5K
- Amount sold
- $300K
- First sale
- Aug 2014
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Zephyrus Biosciences's investors?
- Zephyrus Biosciences's investors include Mission Biocapital.
- How much funding has Zephyrus Biosciences raised?
- Zephyrus Biosciences has disclosed $300K raised across 1 round.
- Where is Zephyrus Biosciences headquartered?
- Zephyrus Biosciences is headquartered in Berkeley, US.